Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$56.80 USD
-0.58 (-1.01%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $56.82 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
Cytokinetics, Incorporated [CYTK]
Reports for Purchase
Showing records 81 - 100 ( 311 total )
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Omecamtiv Prepped for Success; Let''s Get Real About Numbers; Target Increased to $
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Strong Monetization Track Record Continues; Target Increased to $38; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Two Words for Investors for 2H20: Cytokinetics and Omecamtiv; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Mavacamten Meets Pivotal Endpoints in oHCM; CK-274
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Final Agreement Around Reldesemtiv is Achieved; The Hubble Is Focused on GALACTIC
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
COVID-19 Impacts Early Stage Trials but Key 2020 Drivers Remain on Track
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
GALACTIC-HF Continues on Solid Footing; Topline Data in 4Q20; Views on Mavacamten Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Market Shudders But We See Names to Outperform.
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Our Investment Case Is Clear: We Are All in
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Omecamtiv Endgame Now Set; Project Positive Outcome to Be Good for Heart Failure Patients
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
HCM KOL Dinner Takeaways; Excitement Ahead in a Challenging Space
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Omecamtiv Endgame Not Too Far off Now; Expect Significant Boost in CK-274 Visibility in 2020
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Looking to Establish Strong Roots With REDWOOD-HCM
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Spotlight on Omecamtiv at AHA Continues to Strengthen Drug''s Profile
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
3Q19 Results; Priorities and Opportunities Are Clear; Upping Price Target to $30
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
ALS Benefit Remains Clear to Us; Path to Phase 3 Seems Evident as We Await Astellas Visibility
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
CK-274 Confirms Desirable Safety and PK/PD Profile; Randomized Phase 2 Insights
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
2Q19 Results; A Thesis to Pay Attention To; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
1Q19 Results; Cardiac Programs in the Spotlight for Now; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
KOLs Offer Important Perspective About Moving Reldesmtiv Forward
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J